VprBP binds full-length RAG1 and is required for B-cell development and V(D)J recombination fidelity by Kassmeier, Michele D. et al.
VprBP binds full-length RAG1 and is required for
B-cell development and V(D)J recombination fidelity
Michele D Kassmeier1,4, Koushik Mondal1,4,
Victoria L Palmer1,4, Prafulla Raval1,4,5,
Sushil Kumar1,6, Greg A Perry1,
Dirk K Anderson1,7, Pawel Ciborowski2,
Sarah Jackson3, Yue Xiong3 and
Patrick C Swanson1,*
1Department of Medical Microbiology and Immunology, Creighton
University Medical Center, Omaha, NE, USA, 2Department of
Pharmacology and Experimental Neuroscience, University of Nebraska
Medical Center, Omaha, NE, USA and 3Department of Biochemistry and
Biophysics, Lineberger Comprehensive Cancer Center, University of
North Carolina Medical Center, Chapel Hill, NC, USA
The N-terminus of full-length RAG1, though dispensable
for RAG1/2 cleavage activity, is required for efficient V(D)J
recombination. This region supports RING E3 ubiquitin
ligase activity in vitro, but whether full-length RAG1
functions as a single subunit or a multi-subunit E3 ligase
in vivo is unclear. We show the multi-subunit cullin RING
E3 ligase complex VprBP/DDB1/Cul4A/Roc1 associates
with full-length RAG1 through VprBP. This complex is
assembled into RAG protein–DNA complexes, and sup-
ports in-vitro ubiquitylation activity that is insensitive to
RAG1 RING domain mutations. Conditional B lineage-
specific VprBP disruption arrests B-cell development at
the pro-B-to-pre-B cell transition, but this block is
bypassed by expressing rearranged immunoglobulin
transgenes. Mice with a conditional VprBP disruption
show modest reduction of D–JH rearrangement, whereas
VH–DJH and Vj–Jj rearrangements are severely impaired.
D–JH coding joints from VprBP-insufficent mice show
longer junctional nucleotide insertions and a higher
mutation frequency in D and J segments than normal.
These data suggest full-length RAG1 recruits a cullin RING
E3 ligase complex to ubiquitylate an unknown protein(s)
to limit error-prone repair during V(D)J recombination.
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Introduction
B and T lymphocytes have the unique capacity for antigen-
specific recognition, which is mediated by immunoglobulins
(Igs) and T-cell receptors (TCRs), respectively. The exons
encoding the antigen-binding domains of Igs and TCRs
must be assembled from variable (V), joining (J) and some-
times diversity (D) gene segments to gain functionality,
which is achieved through a site-specific DNA rearrangement
process called V(D)J recombination. V(D)J recombination is
understood to occur in two distinct phases: the ‘cleavage
phase’ and the ‘joining phase’ (Fugmann et al, 2000; Gellert,
2002). In the cleavage phase, two different gene segments are
brought into close proximity by two lymphoid cell-specific
proteins, called RAG1 and RAG2, which bind a conserved
sequence element flanking each gene segment, called the
recombination signal sequence (RSS). The RAG proteins then
introduce a DNA double-strand break (DSB) coordinately at the
50 end of each RSS, liberating two blunt signal ends, and two
coding ends terminating in covalently sealed DNA hairpin
structures. After cleavage, the DSBs are subsequently transi-
tioned into the joining phase, during which the DNA ends are
reorganized, processed and joined by components of the non-
homologous end joining (NHEJ) repair pathway (Lieber, 2010).
Typically as a result, the two gene segments become joined to
one another to form a ‘coding joint’ that is often imprecise, and
the two RSSs become precisely joined to create a ‘signal joint’.
RAG protein structure–function analysis reveals that RAG1
can support V(D)J recombination of extrachromosomal and
integrated substrates even when B1/3rd of the protein is
removed from the N-terminus (residues 1–383 of 1040 amino
acids) (Sadofsky et al, 1993; Silver et al, 1993; Kirch et al,
1996). Although dispensable for the basic catalytic activity of
the recombinase, the N-terminus of RAG1 is evolutionarily
conserved (Sadofsky et al, 1993), and is necessary to support
rearrangement of endogenous loci with high efficiency and
fidelity (Dudley et al, 2003; Talukder et al, 2004). The RAG1
N-terminus was recognized to contain a C3HC4 RING finger
domain (Yurchenko et al, 2003), a motif commonly found in
members of a large family of E3 ubiquitin (Ub) ligases that
catalyse Ub transfer in the Ub modification system (Deshaies
and Joazeiro, 2009). In this system, Ub is used to modify
intracellular proteins to regulate their stability or function as
a mechanism to control cellular responses. This process is
achieved through three steps: (i) ATP-dependent loading of
Ub to an Ub-activating enzyme (E1); (ii) transfer of Ub from
the E1 enzyme to a Ub-conjugating enzyme (E2) and
(iii) transfer of Ub from the E2–Ub complex to a lysine
residue of a substrate protein catalysed by an E3 Ub ligase.
Given the presence of a RING finger domain in the RAG1
N-terminus, this region was speculated to regulate V(D)J
recombination by functioning as an E3 Ub ligase to target
itself or other proteins. In support of this possibility, two
studies showed that an isolated RAG1 N-terminal fragment
containing the RING domain supports auto-ubiquitylation
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(Jones and Gellert, 2003), and ubiquitylation of a test sub-
strate in vitro (Yurchenko et al, 2003). Subsequent studies
revealed that RAG1 can promote ubiquitylation of two differ-
ent N-terminal RAG1-interacting proteins, KPNA1 (Simkus
et al, 2009) and histone H3 (Grazini et al, 2010), and perhaps
more specifically the acetylated form of histone H3.3 (Jones
et al, 2011). The functional relevance of RAG1-mediated
ubiquitylation of these substrates remains obscure. It is
notable in this regard that both of these RAG1-interacting
proteins were initially identified in assays using RAG1 only in
the absence of RAG2 (Cortes et al, 1994; Grazini et al, 2010).
Whether RAG1 interactions with RAG2 or other factors alter
the spectrum of targets ubiquitylated by RAG1 is unclear.
Moreover, since many RING-type E3 Ub ligases consist of
multi-subunit assemblies containing various adaptor and
substrate receptor proteins (Deshaies and Joazeiro, 2009),
whether RAG1 functions physiologically as an E3 Ub ligase
independent of accessory proteins, or whether such factors
are required for its ubiquitylation activity towards physiolo-
gical substrates remains to be clarified. Here, we show that
components of a cullin E3 Ub ligase complex that includes
the scaffold protein Cul4A and its associated RING finger
domain protein Roc1 (also called Rbx1), the adaptor protein
damaged DNA binding protein 1 (DDB1), and the substrate
receptor protein Vpr binding protein (VprBP; also called
DCAF1) are all co-purified with full-length RAG1, and that
VprBP is required for B-cell development and high-fidelity
V(D)J recombination.
Results
A complex containing VprBP, DDB1, Cul4A and Roc1
interacts with full-length RAG1
We previously showed that co-expressed N-terminal maltose
binding protein (MBP)-tagged full-length RAG1 and core
RAG2 purified under mild conditions (FLMR1/cMR2) support
formation of a RAG–RSS complex containing two NHEJ
factors, Ku70 and Ku80, detectable by electrophoretic mobi-
lity shift assay (EMSA) (this complex is called RAG/Ku–RSS)
(Raval et al, 2008). In these experiments, Ku70/Ku80 failed to
supershift a lower order RAG–RSS complex assembled with
FLMR1/cMR2, suggesting an unidentified bridging molecule
or cofactor mediates the RAG–Ku interaction (Raval et al,
2008). In support of this hypothesis, FLMR1/cMR2 prepara-
tions routinely showed two additional protein bands on SDS–
PAGE gels, called p120 and p170, which were absent in RAG
preparations containing core RAG1 and either core or full-
length RAG2 (Figure 1A). Using mass spectrometry, p170 was
identified as VprBP (also called DCAF1) (Figure 1B). VprBP is
a member of the WD40-repeat family of proteins (Lee and
Zhou, 2007), and reportedly functions as a substrate receptor
in at least two different E3 Ub ligase complexes in non-
lymphoid cells: the RING-type DDB1/Cul4A/Roc1 complex
(Huang and Chen, 2008) and the HECT-type DDB1/DYRK2/
EDD complex (Maddika and Chen, 2009). Because DDB1 is a
127-kDa protein that co-purifies with VprBP in nearly equiva-
lent amounts (Wen et al, 2007), we speculated that p120 was
DDB1. Immunoblotting confirmed the presence of VprBP,
DDB1 and Cul4A and Roc1 (weakly) in preparations of
FLMR1/cMR2, but not cMR1/cMR2 and cMR1/FLMR2
(Figure 1C). DYRK2 and EDD were not detected in purified
FLMR1/cMR2 preparations (Supplementary Figure S1A), sug-
gesting they are not stably integrated into an E3 Ub ligase
complex containing full-length RAG1.
VprBP/DDB1 associates with FLMR1/cMR2 and Ku
in a higher order protein–DNA complex
Having established that VprBP, DDB1, Cul4A and Roc1 (here-
after termed the VDCR complex) co-purify with FLMR1/
cMR2, we asked whether any of these components are
present in the higher order RAG/Ku–RSS complex that is
detected in binding reactions containing FLMR1/cMR2 but
not cMR1/cMR2 (Figure 1D, compare lanes 1 and 4). We
focused on VprBP because of its putative role as substrate
receptor for E3 Ub ligases. We found that anti-VprBP anti-
serum, but not pre-immune serum, specifically depleted the
RAG/Ku–RSS complex, but not the lower order RAG–RSS
complex in the same lane (Figure 1D, compare lanes 5 and 6).
In addition, VprBP/DDB1 purified from insect cells with or
without Cul4A and Roc1 did not supershift RAG–RSS com-
plexes assembled with cMR1/cMR2, but stimulated forma-
tion of the higher order RAG/Ku–RSS complex in samples
containing FLMR1/cMR2 (Figure 1E, compare lane 4 with
lanes 5 and 6, and lane 7 with lanes 8 and 9). This result
suggests VprBP/DDB1 is stably integrated into the RAG/Ku–
RSS complex. Consistent with this notion, VprBP-specific
antibody supershifted the RAG/Ku–RSS complex in all sam-
ples containing FLMR1/cMR2 regardless of whether Cul4A/
Roc1 was present (Figure 1E, compare lanes 7–9 with 10–12).
These data suggest Cul4A and Roc1 are dispensable for stable
association of VprBP/DDB1 with the RAG/Ku–RSS complex.
RAG1 interactions with VprBP are primarily mediated
by the WD40 motif of VprBP and the far N-terminus of
full-length RAG1
Because VprBP functions as a substrate receptor for other E3
Ub ligases, we suspected that VprBP directly interacts with
FLMR1/cMR2. To test this possibility, we incubated purified
FLMR1/cMR2 with purified full-length human VprBP (FL),
an N-terminal truncation mutant lacking the C-terminal
WD40 repeats and acidic tail (D1), or truncation mutants
containing only the WD40 repeats (D5), or the acidic tail (D8)
(Figure 2A), and then immunoprecipitated the RAG proteins
and probed for VprBP by immunoblotting. We found that
both full-length VprBP and the D5 fragment readily co-
immunoprecipitated (co-IP) with the RAG proteins, but the
D1 and D8 fragments did so poorly (D1) or not at all (D8)
(Figure 2B). Interestingly, in samples containing full-length
VprBP, a contaminating N-terminal VprBP fragment is recov-
ered after IP. This fragment is present in the input and is
smaller than the D1 fragment, yet D1 itself associates only
weakly with FLMR1/cMR2 (Figure 2B). This outcome is most
easily explained if full-length VprBP not only interacts with
FLMR1/cMR2 through its WD40 motif, but also associates
directly or indirectly with the truncated VprBP fragment. This
interaction is most likely indirect, because the LisH motif,
which reportedly mediates VprBP oligomerization (Ahn et al,
2011), should not be present in the truncated fragment based
on its apparent molecular mass (Figure 2B). Alternatively,
full-length VprBP may associate with the truncated VprBP
fragment through DDB1, because DDB1 co-purifies with both
full-length VprBP and the D1 fragment (Supplementary
Figure S1A and B). Notably, these experiments rule out the
possibility that the RAG proteins directly interact with DDB1,
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because the D1 but not D5 preparation was found to
contain DDB1 (Supplementary Figure S2A and B), yet D5
readily bound to FLMR1/cMR2, but D1 did so poorly
(Figure 2B).
To further narrow the region within the RAG1 N-terminus
required for VprBP association, we probed a previously
prepared panel of N-terminal MBP–RAG1 truncation mutants
(Raval et al, 2008) (co-purified with cMR2 and normalized for
RAG1 levels) for the presence of endogenous VprBP
(Figure 2C). We found that VprBP levels are substantially
reduced when the first 150 residues of RAG1 are removed;
truncation of an additional 60 residues largely abolishes
VprBP association (Figure 2C). Thus, VprBP primarily inter-
acts with the first 150 residues of RAG1. We also probed an
individually expressed and purified form of MBP–RAG1 con-
taining only the N-terminal region (residues 1–383; called
MR11–383) and found that this region was sufficient to mediate
the association with VprBP (Figure 2C). Immunoblotting also
confirmed the presence of DDB1, Cul4A and Roc1 in this
preparation (unpublished observations).
FLMR1/cMR2 supports RAG1 RING-independent E3
Ub ligase activity in vitro
An isolated RAG1 N-terminal fragment containing the RING
domain has been reported to undergo auto-ubiquitylation
and mediate ubiquitylation of KPNA1 in vitro (Simkus et al,
2009). Histone H3 was subsequently identified as a putative
target of RAG1-mediated ubiquitylation (Grazini et al, 2010),
with the acetylated form of the histone variant H3.3 possibly
a more specific target (Jones et al, 2011). In addition, both
RAG2 and Ku70 are reported targets for ubiquitylation by
other Ub ligases (Mizuta et al, 2002; Jiang et al, 2005; Gama
et al, 2006). To determine whether one or more of these
proteins are ubiquitylated by FLMR1/cMR2, we established
an in-vitro ubiquitylation reaction using conditions similar to
those reported by others (Jones and Gellert, 2003; Yurchenko
et al, 2003; Simkus et al, 2009). Because Ub ligase activity is
influenced by the choice of E2 Ub-conjugating enzyme used
in the reaction, we first tested a panel of E2 enzymes, chosen
based on these previous studies, for their ability to promote
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Figure 1 VprBP and DDB1 associate with full-length RAG1 and core RAG2 and assemble a higher order RAG–RSS complex. (A) SYPRO orange-
stained SDS–PAGE gels of core and full-length RAG1 and RAG2 preparations purified from HEK293 cells revealed two co-purifying proteins,
p120 and p170, in the FLMR1/cMR2 preparation (arrows). Consistent with previous results (Raval et al, 2008), the expression and recovery of
full-length RAG1 are slightly lower than for core RAG1. Protein standards to determine apparent molecular weight (M) were run in lane 1.
Forms of maltose binding protein (MBP)-tagged RAG1 and RAG2 are designated below the gel. (B) Peptide sequences identified by mass
spectroscopy of trypsin-digested p170. The position of the peptides in the VprBP sequence, the number of times they are represented in the
sample, and their presence in multiple, independent samples are indicated in brackets, parentheses, and by an asterisk, respectively.
(C) Immunoblots of RAG protein preparations in (A) using antibodies against MBP, VprBP, DDB1, Cul4A and Roc1, as indicated at right. A
sample of whole cell lysate prepared from HEK293 cells (293 WCL) was run along with the RAG protein preparations as a positive control. By
SDS–PAGE, all four full-length RAG1-associated proteins migrated to positions consistent with their predicted molecular weight (VprBP,
169 kDa; DDB1, 127 kDa; Cul4A, 80 and 82 kDa; and Roc1, 12 kDa). (D) cMR1/cMR2 or FLMR1/cMR2 was incubated with a radiolabelled
12-RSS in the absence or presence of pre-immune or anti-VprBP anti-serum (Zhang et al, 2001), and RAG–RSS complex formation visualized by
EMSA. (E) cMR1/cMR2 or FLMR1/cMR2 binding to a 12-RSS was analysed by EMSA in the absence or presence of purified VprBP/DDB1 and
VprBP/DDB1/Cul4A/Roc1 (expressed in insect cells; VD and VDCR, respectively) and with or without subsequent addition of anti-VprBP
antibody as indicated. Figure source data can be found in Supplementary data.
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purified FLMR1/cMR2, but not cMR1/cMR2, supported ro-
bust E2-dependent de-novo ubiquitylation in vitro in the
presence of the E2 enzymes UbcH5a and H5b, but not the
other E2 enzymes tested (Figure 3A, top). When these blots
were reprobed using MBP-specific antibodies (to detect the
RAG proteins), no evidence of de-novo ubiquitylation was
detected, suggesting that neither RAG1 nor RAG2 is efficient
target of RAG1-mediated (auto)ubiquitylation under these
conditions (Figure 3A, bottom).
To determine whether ubiquitylation was mediated
directly by RAG1, we tested whether an RAG1 RING domain
mutation (hC328Y) associated with human Omenn’s
syndrome (Villa et al, 2001) impaired Ub conjugation in our
in-vitro system. Previous studies have shown that, compared
with wild-type (WT) RAG1, a murine equivalent of the
human mutant, mC325Y RAG1, exhibits defects in protein
folding and reduced activity in assays of auto-ubiquitylation
and V(D)J recombination (Simkus et al, 2007). For these
studies, we prepared not only the mC325Y RAG1 mutant,
but also generated an mC328Y RAG1 mutant, because this
cysteine residue also participates in zinc ion coordination
(Rodgers et al, 1996). Consistent with previous results, we
found that both RAG1 RING domain mutants showed evi-
dence of protein misfolding as indicated by an increase in
endogenous proteolysis and an associated reduction in pro-
tein recovery after purification (Supplementary Figure S3A),
as well as severely impaired V(D)J recombination activity in
assays of signal and coding joint formation (Supplementary
Figure S3C and D). Interestingly, both RAG1 mutants sup-
ported in-vitro ubiquitylation at levels comparable to WT
FLMR1/cMR2, suggesting that full-length RAG1 does not
directly mediate ubiquitylation in this system (Figure 3B),
and raises the possibility that the VDCR complex instead
mediates ubiquitylation. In support of this hypothesis, both
purified VprBP/DDB1 and Cul4A/DDB1 supported in-vitro
ubiquitylation in the presence of UbcH5b, but adding
FLMR1/cMR2 slightly stimulates this activity in vitro
(Figure 3C). To determine whether ubiquitylation activity in
this experimental system is RAG2 dependent, or dependent
on the core region of RAG1, we tested whether purified
FLMR1 alone or MR11–383 mediated ubiquitylation in vitro.
We found that, like FLMR1/cMR2, both FLMR1 alone and
MR11–383 supported a similar pattern of E2-dependent ubi-
quitylation in the presence of UbcH5a and UbcH5b (Figure
3D and E), suggesting that neither RAG2 nor the core portion
of RAG1 is required for ubiquitylation activity in this system.
Interestingly, when FLMR1 and FLMR1/cMR2 preparations
were directly compared in this assay (Figure 3F), FLMR1
showed higher levels of ubiquitylation, suggesting RAG2
may partially inhibit full-length RAG1 ubiquitylation activity
in vitro.
The failure of RAG1 RING domain mutations to impair
in-vitro ubiquitylation activity suggests that such mutations
disrupt V(D)J recombination by an alternative mechanism.
Consistent with this possibility, we found that the RAG1 RING
domain mutants exhibit a defect at the cleavage step of V(D)J
recombination, as both the mC325Y and mC328Y FLMR1/
cMR2 preparations supported lower levels of signal end
break (SEB) formation in cells compared with WT FLMR1/
cMR2 as detected by ligation-mediated PCR (LM-PCR;
Supplementary Figure S3E and F). We attribute the poor
cleavage activity of the mutants to a DNA binding defect,
because neither the mC235Y or mC328Y FLMR1/cMR2 pre-
paration supported detectable RAG–RSS complex formation
by EMSA (Supplementary Figure S3B).
Since KPNA1 and histone H3 have been reported to
associate with and be ubiquitylated by RAG1 (Simkus et al,
2009; Grazini et al, 2010), we tested whether either protein
was present in purified FLMR1/cMR2, and indeed detected
both proteins by immunoblotting (Supplementary Figure
S1B). However, in-vitro ubiquitylation experiments failed to
provide convincing evidence that KPNA1 or histone H3
(variant H3.1, 3.2 or 3.3) undergoes full-length RAG1-depen-
dent ubiquitylation, either in reactions supplemented with
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Figure 2 Full-length RAG1 primarily interacts with the WD40 motif
of VprBP. (A) Diagram of full-length and truncated forms of VprBP
used in this study. A summary of VprBP binding activity from (B) is
shown at right. The location of a proteolytic site in full-length
VprBP is indicated by an asterisk. (B) Full-length or truncated
VprBP fragments in (A) were incubated with purified FLMR1/
cMR2 in vitro and VprBP binding was assessed by immunoprecipi-
tation (IP) using anti-MBP antibodies followed by immunoblotting
(IB) with the indicated antibodies; 5% of the binding reaction was
probed directly as a control (input). Note that a proteolytic VprBP
fragment present in the input full-length VprBP preparation (in-
dicated by an asterisk) is also recovered after IP (see text for
details). (C, D) Preparations of MBP-tagged RAG1 truncation mu-
tants co-purified with cMR2 described previously (Raval et al, 2008)
were normalized for RAG1 and analysed by IB to detect RAG1 and
VprBP. An individually expressed and purified form of MBP–RAG1
containing only the N-terminal region (MR11–383) was similarly
analysed.
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Figure 3 Purified FLMR1/cMR2 supports RING-independent ubiquitylation of an unknown target protein, but does not undergo efficient
auto-ubiquitylation in vitro. (A) In-vitro ubiquitylation reactions containing wild-type (WT) FLMR1/cMR2, myc–Ub, E1 and various E2
carrier proteins were assembled as indicated, incubated as described in Materials and methods, and probed by IB using the antibodies at
left. (B) In-vitro ubiquitylation reactions containing WT, mC325Y, or mC328Y FLMR1/cMR2 preparations were assembled and analysed
as in (A) using UbcH5a as the E2 carrier. (C) In-vitro ubiquitylation reactions were assembled as in (A) using UbcH5b as the E2 carrier
protein, except that some reactions were further supplemented with 293 cell-purified FLAG-tagged VprBP (lanes 5, 7 and 9) and/or Cul4A
(lanes 6, 7 and 9). Reactions were analysed as in (A). (D, E) In-vitro ubiquitylation reactions were assembled and analysed as in (A),
except that FLMR1/cMR2 was replaced by individually expressed and purified FLMR1 (D) or MR11–383 (E). (F) In-vitro ubiquitylation
reactions containing wild-type FLMR1 or FLMR1/cMR2 preparations were assembled and analysed as in (A) using UbcH5a as the E2 carrier
protein. Figure source data can be found in Supplementary data.
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reactions containing only the endogenous co-purified pro-
teins (unpublished observations). We also performed in-vitro
ubiquitylation reactions using Ku70 and Ku80 as test sub-
strates based on our previous studies showing that both
proteins associate with full-length RAG1 (Raval et al, 2008),
but these experiments yielded equivocal results as well
(Supplementary Figure S4D). Since the evidence suggests
that KPNA1, histone H3 and Ku70/80 are not robust ubiqui-
tylation targets in this experimental system, we performed a
time-course study to determine whether mono-ubiquitylation
of a smaller protein is detectable early in the reaction.
However, even at the earliest time points, only high molecu-
lar weight ubiquitylated products were detected, which accu-
mulate over time and progress towards higher order
polyubiquitylated products that fail to enter the polyacryla-
mide gel (Supplementary Figure S4E). Taken together, these
experiments favour a model in which FLMR1 recruits the
VDCR complex to target one or more proteins for ubiquityla-
tion that are distinct from those previously shown to be
ubiquitylated by RAG1. However, we cannot formally exclude
the possibility that in this experimental system, a small
protein in limited abundance is targeted for ubiquitylation,
but cannot be readily detected until it becomes polyubiqui-
tylated. Such a possibility would make it difficult to identify
the target.
Conditional disruption of VprBP expression in the B
lineage blocks B-cell development at the pro-B-to-pre-B
cell transition by triggering cell-cycle arrest and
apoptosis
If the VDCR complex plays an essential role in V(D)J recom-
bination, disrupting expression of one or more of these
components early in lymphocyte development would be
expected to arrest maturation at a developmental stage
similar to that observed in RAG-deficient mice. In the B
lineage, conventional gene-targeted disruption of RAG1 or
RAG2 arrests maturation at the pro-B-to-pre-B cell transition
(Mombaerts et al, 1992; Shinkai et al, 1992). Because VprBP
is a known substrate receptor for E3 Ub ligases (Huang and
Chen, 2008; Maddika and Chen, 2009) and directly interacts
with RAG1 (Figure 2), we wished to test whether loss of
VprBP function impairs lymphocyte development and V(D)J
recombination. However, since conventional VprBP disrup-
tion causes early embryonic lethality (McCall et al, 2008), we
instead employed a Cre-loxP approach to conditionally dis-
rupt VprBP expression in the B lineage using mb1-Cre trans-
genic mice that express Cre from the very early pro-B cell
stage onwards (Creþ ) (Hobeika et al, 2006), and mice bear-
ing a conditional VprBP allele in which exons 7 and 8 are
flanked by loxP sites (VprBPfl; see Figure 4A and McCall et al,
2008).
Bone marrow, spleens and thymi were collected from 4- to
6-week-old WT, VprBPfl/þ -Cre, VprBPfl/fl-Cre, VprBPfl/þ -
Creþ , VprBPfl/fl-Creþ and RAG1/ mice and B- and T-cell
developmental subsets were analysed by flow cytometry
(Figure 4B; Supplementary Figure S5). We found that
VprBPfl/þ -Cre, VprBPfl/fl-Cre and VprBPfl/þ -Creþ mice
immunophenotypically resembled each other and WT mice.
Strikingly, compared with VprBPfl/þ -Creþ mice, VprBPfl/fl-
Creþ mice exhibited a profound block at the pro-B-to-pre-B
cell transition, as evidenced by a five-fold (Po0.005) de-
crease in bone marrow B220þCD43 cells, whereas the
frequency of B220þCD43þ cells was unaffected (Figure 4B,
first row; Figure 4C). Within the B220þCD43þ subset, pre/
pro-B cell (CD19CD24) and pro-B cell (CD19þCD24þ )
fractions were not significantly different between the geno-
types (Supplementary Figure S5A). Consistent with a block in
early B-cell development, few if any B cells with an immature
(IgMþ IgD) or mature (IgMþ IgDþ ) phenotype were de-
tected in bone marrow or spleen of VprBPfl/fl-Creþ mice
(Figure 4B, second and third rows; Figure 4C). The B-cell
developmental block observed in VprBPfl/fl-Creþ mice is very
similar to that reported for RAG1/ mice and reproduced
here (Shinkai et al, 1992; Spanopoulou et al, 1994; Figure 4B,
compare last two columns). As expected from the B-lineage
restricted Cre expression in this system, VprBPfl/fl-Creþ mice
exhibited no significant differences in the abundance or
distribution of T-cell subsets compared with WT, VprBPfl/þ -
Cre and VprBPfl/þ -Creþ mice (Supplementary Figure S5B),
but were distinct from RAG1/ mice which showed a block
in T-cell development at the CD4CD8 stage (Supplemen-
tary Figure S5B). Consistent with a profound block in B-cell
development, spleen cellularities in VprBPfl/fl-Creþ mice
were about 25% lower than in VprBPfl/þ -Creþ mice
(6.9±2.5106 versus 9.0±2.1106, respectively), whereas
total bone marrow and thymic cellularities were similar.
To investigate the mechanism of impaired pro-B-to-pre-B
cell progression in VprBPfl/fl-Creþ mice, bone marrow
B220þCD43þ and B220þCD43 B-cell subsets were sorted
from VprBPfl/þ -Cre, VprBPfl/þ -Creþ , VprBPfl/fl-Creþ and
RAG1/ mice and analysed for differences in the frequency
of early and late apoptotic cells (defined as staining positive
for Annexin V and either negative (early) or positive (late) for
propidium iodide, respectively) and cell-cycle status. We
found that the percentages of apoptotic cells and cells in
the G1, S and G2 phases of the cell cycle among sorted
B220þCD43þ B cells were not significantly different between
the various genotypes (Figure 5A). By contrast, relative to
VprBPfl/þ -Creþ mice, sorted B220þCD43 B cells from
VprBPfl/fl-Creþ mice showed a significant B3-fold increase
in late apoptotic cells (Annexin VþPIþ ) and a similar in-
crease in S phase cells (Figure 5B). These results were similar
to those obtained from RAG1/ mice analysed in parallel
(Figure 5B). Taken together, these data suggest that B cells
emerging from the B220þCD43þ cell stage in VprBPfl/fl-Creþ
mice enter cell cycle, but fail to transit through S phase,
triggering the onset of apoptosis.
Enforced Ig transgene expression rescues B-cell
development in VprBPfl/fl-Creþ mice
To exclude the possibility that the block in B-cell develop-
ment observed in VprBPfl/fl-Creþ mice is independent of
V(D)J recombination, we bred functionally rearranged
heavy and light chain transgenes specific for hen egg lyso-
zyme (IgHEL) onto the VprBPfl/fl-Creþ strain background.
We reasoned that if VprBP is directly involved in V(D)J
recombination, IgHEL expression should enable developing
B cells to bypass the developmental block imposed by loss of
VprBP function, by analogy to comparable experiments per-
formed in RAG1/ mice (Spanopoulou et al, 1994).
Consistent with this expectation, flow cytometric analysis of
IgHEL-expressing VprBPfl/fl-Creþ mice revealed an increased
percentage of B220þCD43 B cells in the bone marrow
relative to VprBPfl/fl-Creþ mice (Figure 6A, top row;
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Figure 6B), and the presence of phenotypically mature B cells
in the bone marrow and spleen (Figure 6A, second and third
rows; Figure 6B). The frequency of cells comprising the
various bone marrow and splenic B-cell subsets was not
significantly different between VprBPfl/þ -Creþ IgHELþ and
VprBPfl/fl-Creþ IgHELþ mice (Figure 6B). Splenic CD19þ B
cells in VprBPfl/fl-Creþ IgHELþ mice were also stained by
Alexa647-conjugated HEL (HELþ ), confirming functional
IgHEL transgene expression (Figure 6A, bottom row). This
staining is specific because IgHEL mice showed no evidence
Wild-type allele
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Figure 4 Conditional disruption of VprBP impairs B-cell development. (A) Diagram of wild-type, targeted and deleted VprBP alleles, adapted
from McCall et al (2008). (B) Flow cytometric analysis of B-cell development. Mice bearing 0, 1 or 2 targeted VprBP alleles (WT, VprBPfl/þ or
VprBPfl/fl, respectively) that do or do not express Cre recombinase in the B lineage (Creþ or Cre) as indicated above the panel were analysed
for the expression of B220 and CD43 (top row) or sIgM and sIgD (middle and bottom rows) on cells prepared from bone marrow (BM) or spleen
(SPL) and identified by the gating parameters shown below each row. Developmental subsets specified by the staining pattern are indicated at
right with corresponding gates. The percentage of cells within identified gates or quadrants are shown for representative animals. (C) Data
collected from 3 to 4 animals of each genotype for the BM samples in (B) are summarized in bar graph format. Statistically significant
differences determined from analysis of variance and post hoc testing using an unpaired t-test are indicated. Results obtained from analysis of
sIgM and sIgD expression in SPL were comparable to BM.
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of CD19þHELþ cells. Taken together, these data argue that
VprBP is required for B-cell development through a specific
role in V(D)J recombination.
VprBPfl/fl-Creþ mice exhibit impaired VH–DJH and
Vj–DJj rearrangements, and loss of VprBP expression is
associated with reduced fidelity of V(D)J recombination
Given the profound block in B-cell development observed in
VprBPfl/fl-Creþ mice, we wished to determine whether loss of
VprBP function in the B-cell lineage impairs the efficiency of
V(D)J recombination. Towards this end, genomic DNA pre-
pared from bone marrow of VprBPfl/þ -Cre, VprBPfl/þ -
Creþ , VprBPfl/fl-Creþ and control RAG1/ mice was sub-
jected to PCR and Southern blotting to analyse the status of Ig
heavy chain D–JH and VH–DJH rearrangements. We found
that the pattern of D–JH rearrangements in bone marrow was
quite similar between VprBPfl/þ -Cre, VprBPfl/þ -Creþ and
VprBPfl/fl-Creþ mice (Figure 7, top panel). However,
VH–DJH rearrangements were substantially diminished in
VprBPfl/fl-Creþ mice compared with VprBPfl/þ -Cre and
VprBPfl/þ -Creþ mice (Figure 7, middle panel). This was
also true for Vk–Jk rearrangements, which is consistent with
the failure of B cells to progress past the pre-B cell stage of
development in VprBPfl/fl-Creþ mice (Figure 7, bottom
panel). As expected, control RAG1/ mice showed no
evidence of heavy or light chain V(D)J rearrangements.
To more closely examine the fidelity of V(D)J recombina-
tion, we amplified D–JH4 coding joints and analysed the
nucleotide sequences from B50 clones obtained from
VprBPfl/þ -Cre, VprBPfl/þ -Creþ and VprBPfl/fl-Creþ mice
(Supplementary Figure S6A and B). We found that among
sequences with nucleotide (nt) insertions that include both
palindromic (P) and non-templated (N) additions, the aver-
age insertion length was longer in VprBPfl/þ -Creþ mice
(3.42±0.33 nt) and VprBPfl/fl-Creþ mice (3.23±0.40 nt)
compared with VprBPfl/þ -Cre mice (2.74±0.39 nt), but
these differences were not statistically significant (Table I).



















































































































































































































Figure 5 Developing B cells in VprBPfl/fl-Creþ and RAG1/ mice similarly undergo cell-cycle arrest and apoptosis at the pro-B-to-pre-B cell
transition. (A) B220þCD43þ and (B) B220þCD43 B cells were purified by FACS from bone marrow of VprBPfl/þ -Cre, VprBPfl/þ -Creþ ,
VprBPfl/fl-Creþ and RAG1/ mice as indicated above the panels (stained and gated as in Figure 3, top row), and stained with Annexin V and
propidium iodide (top row) to analyse the extent of cell apoptosis, or stained with Vindelov’s reagent (bottom row) to analyse cell-cycle status.
The percentage of cells within each quadrant or cell-cycle phase is shown. Data collected from three independent experiments were analysed
and displayed as in Figure 4C.
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the JH segments was longer for VprBP
fl/þ -Creþ mice
(5.75±0.60 nt) and VprBPfl/fl-Creþ mice (4.38±0.64 nt)
compared with VprBPfl/þ -Cre mice (4.13±0.44 nt), but
these differences were only significant between VprBPfl/þ -
Creþ mice and VprBPfl/þ -Cre mice (Table I). Interestingly,
we also detected an unexpectedly high frequency of small
internal insertions, deletions, or mutations in the D and J
segments analysed from VprBPfl/þ -Creþ mice (4/53 clones)
and VprBPfl/fl-Creþ mice (7/47 clones), whereas none were
detected in sequences analysed from VprBPfl/þ -Cre mice
(Table I; Supplementary Figure S6A–C). In this case, differ-
ences between VprBPfl/fl-Creþ mice and VprBPfl/þ -Cre
mice were statistically significant. Two features of the muta-
tions are worth noting. First, all mutations identified were
transition mutations. Second, all mutations were found in
sequences that also had N nucleotide additions or D segment
insertions. Finally, we analysed the sequences for evidence of
microhomology-directed repair, and identified 5–6 clones
from each mouse genotype containing putative microhomol-
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Figure 6 Expression of functionally rearranged IgHEL transgenes bypasses the developmental block imposed by VprBP deficiency in the B
lineage. (A) VprBPfl/þ or VprBPfl/fl mice expressing Cre and/or IgHEL transgenes as indicated above the panels were analysed for the
expression of B220 and CD43 (top row), sIgM and sIgD (second row), and CD19 and HEL (bottom row) on cells prepared from bone marrow
(BM) or spleen (SPL) as in Figure 4. (B) Data collected from 3 to 4 animals of each genotype for B220 versus CD43 and sIgM versus sIgD
expression were analysed and displayed as in Figure 4C.
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Interestingly, although the frequency of microhomology use
is similar, all clones identified from VprBPfl/þ -Cremice only
had short regions of homology (n¼ 2 nt), whereas 3–4 clones
identified from VprBPfl/þ -Creþ mice and VprBPfl/fl-Creþ
mice had longer blocks of homology (n¼ 3–4 nt). Notably,
2/5 clones containing microhomologies identified from
VprBPfl/fl-Creþ mice also contained D segment insertions.
Taken together, these data suggest that loss of VprBP function
reduces the fidelity of DNA end processing and repair events
during V(D)J recombination.
Discussion
Full-length RAG1 assembles an E3 Ub ligase complex
with E3 ligase adaptor and substrate receptor proteins
DDB1 and VprBP
RING E3 Ub ligases often contain multiple subunits that
include a RING domain-containing protein, as well as various
adaptor and substrate receptor proteins (Deshaies and
Joazeiro, 2009). Although the RAG1 RING finger is known
to possess E3 Ub ligase activity in vitro, supporting both auto-
ubiquitylation (Jones and Gellert, 2003) and ubiquitylation of
KPNA1 (Simkus et al, 2009) and histone H3 (Grazini et al,
2010; Jones et al, 2011), it is unclear whether full-length RAG1
functions as a single subunit E3 Ub ligase, or rather associates
with other accessory proteins to assemble a multi-subunit E3
Ub ligase complex. The finding here that full-length RAG1
associates with the VprBP/DDB1 complex, which is known to
function as an E3 Ub ligase adaptor and substrate receptor
complex for both RING-type and HECT-type E3 Ub ligases
(Huang and Chen, 2008; Maddika and Chen, 2009; Li et al,
2010), favours the latter possibility.
Whether the RAG1 RING domain functions to directly
mediate ubiquitylation of protein targets in the context of
full-length RAG1 or in the presence of RAG1-interacting
factors remains unclear. Using conditions similar to those
reported previously, we find that the purified FLMR1/cMR2–
VDCR complex does not support RAG1 auto-ubiquitylation,
or mediate efficient ubiquitylation of two previously identi-
fied targets of in-vitro RAG1 E3 Ub ligase activity, KPNA1 or
histone H3, or promote ubiquitylation of RAG2 or the Ku
proteins. However, the FLMR1/cMR2–VDCR complex does
support ubiquitylation of an as-yet unidentified substrate(s)
in vitro in the presence of UbcH5a or Ubc5b, but this activity
is not sensitive to RAG1 C325Y and C328Y RING domain
mutations, and occurs independently of RAG2 or the core
portion of RAG1. While these results do not preclude the
possibility that the RAG1 RING domain functions to directly
ubiquitylate protein targets, at the very least our findings
indicate that the spectrum of targets potentially ubiquitylated
by RAG1 is influenced by factors that associate with full-
length RAG1.
Alternatively, because the VDCR complex also co-purifies
with the RAG1 RING domain mutants tested in our studies,
it is possible that full-length RAG1 does not directly mediate
ubiquitylation, but rather recruits another E3 ligase complex
to accomplish this task. Indeed, this possibility was raised
recently (Jones et al, 2011) to explain the apparently modest
sensitivity of full-length RAG1-mediated histone H3 ubiqui-
tylation to RAG1 RING domain mutations reported by others
(Grazini et al, 2010). Our findings are consistent with this
possibility, and further suggest that the far N-terminus of
RAG1 acts as a scaffold to recruit the VDCR complex to direct
its E3 Ub ligase activity. Because the Roc1/Cul4A/DDB1
complex has previously been implicated in mediating ubiqui-
tylation of histones H3 and H4 (Wang et al, 2006), our results
also provide a plausible alternative mechanism to explain the
origin of the ubiquitylated histones detected by Grazini et al
(2010).
Another interesting finding to emerge from the in-vitro
ubiquitylation assays is that the FLMR1 alone supports great-
er ubiquitylation activity than the FLMR1/cMR2 (Figure 3F).
Since RAG2 undergoes periodic degradation during the cell
cycle (Desiderio, 2010), this observation raises the intriguing
possibility that RAG1 ubiquitylation activity (mediated either
directly or indirectly by full-length RAG1), is unmasked or
upregulated when RAG2 is degraded.
The finding that RAG1 C325Y and C328Y RING mutants
characterized here support less RSS cleavage activity than
WT RAG1 contrasts with results from a previous study of two
similar RAG1 RING mutants (H307A and C325G single or
double mutants) that showed SEB accumulation for RAG1
mutants by LM-PCR, but no detectable SEBs for WT RAG1





























Figure 7 VH–DJH and Vk–Jk rearrangements, but not D–JH rearran-
gement, are severely impaired in VprBPfl/fl-Creþ mice. Genomic
DNA (200–3 ng) isolated from the bone marrow of VprBPfl/þ -Cre,
VprBPfl/þ -Creþ , VprBPfl/fl-Creþ and RAG1/ mice was subjected
to PCR–Southern blotting to detect D–JH, VH–DJH and Vk–Jk gene
rearrangements as indicated. PCR amplification of a CD14 gene
fragment serves as a loading control in these experiments.
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outcome to efficient signal joint formation, and therefore
concluded that the RAG1 mutants exhibit a defect in the
joining step rather than the cleavage step of V(D)J recombi-
nation. However, it is difficult to ascertain from this experi-
ment how much signal one might have expected to observe
with the number of SEBs WT RAG1 would introduce in the
substrate in the absence of DNA repair. As a result, it is
plausible that more SEBs were introduced by WT RAG1 than
the RAG1 mutants, but the WT, but not mutant, RAG1-
induced SEBs were repaired efficiently. If so, both the clea-
vage and joining steps may be impaired by the RAG1 RING
mutations, which would be consistent with what we observe.
VprBP regulates post-cleavage processing and repair
of RAG-mediated DNA breaks
Genetic evidence presented here suggests loss of VprBP
function alters the processing and repair of RAG-mediated
DNA breaks. Addition of non-templated nucleotides after
hairpin resolution (N nucleotides) is attributed to the activity
of members of the pol X family of polymerases, including
TdT, and DNA polymerases m (pol m) and l (pol l) (Bertocci
et al, 2006). The increased average length of inserted nucleo-
tides observed in coding joints amplified from VprBPfl/þ -
Creþ and VprBPfl/fl-Creþ mice suggests VprBP plays a role in
regulating terminal transferase activity during the repair of
RAG-induced DNA breaks. This possibility gains credibility
by the unexpected observation that VprBPfl/þ -Creþ and
VprBPfl/fl-Creþ mice also exhibit a higher frequency of
mutations in flanking D and J segments. Filling of 30 recessed
ends or short gaps during V(D)J recombination of the heavy
chain locus is attributed to pol l activity (Bertocci et al,
2006). The spectrum of mutations that are introduced in
VprBPfl/þ -Creþ and VprBPfl/fl-Creþ mice D–JH coding joints
includes mainly transition mutations, and single nucleotide
deletions and insertions. Biochemical analysis of pol l fidelity
indicates that this enzyme has a misincorporation profile
favouring transition over transversion mutations, and also
exhibits a high single-base deletion rate and possesses term-
inal transferase activity (Fiala et al, 2004; Yamtich and
Sweasy, 2010). The similarity between the spectrum of muta-
tions in VprBPfl/þ -Creþ and VprBPfl/fl-Creþ mice and the
characteristics of pol l fidelity raises the possibility that
VprBP regulates pol l activity directly or indirectly through
an Ub-dependent mechanism. It is also interesting that 6/7
sequences containing transition mutations occur in coding
joints that also bear N nucleotide additions. This observation
suggests that N addition may be coupled to error-prone gap
filling events mediated by pol l. Similarly, the observation
that the two clones containing D segment nucleotide inser-
tions obtained from VprBPfl/fl-Creþ mice also contain blocks
of microhomology suggests such insertions are frequently
associated with microhomology-directed repair.
We recognize that pol l-deficient mice and mice expressing
core RAG1 (lacking the N-terminus) in place of full-length
RAG1 do not exhibit the striking developmental arrest at the
pro-B-to-pre-B cell transition we observe in VprBPfl/fl-Creþ
mice (Dudley et al, 2003; Bertocci et al, 2006). This apparent
discrepancy suggests that VprBP plays a role in B-cell devel-
opment beyond its potential involvement in improving the
efficiency and fidelity of V(D)J recombination through its
association with full-length RAG1 or its regulation of pol l
activity. Since VprBP has been shown to function as a
substrate receptor for other E3 Ub ligase assemblies (see
below), it is possible that VprBP functions in the context of
additional E3 Ub ligase complexes to target distinct substrates
to regulate other pathways activated during V(D)J recombi-
nation. However, we emphasize that any potential require-
ment for VprBP in these other pathways can be bypassed
in the B lineage by expressing functionally rearranged Ig
transgenes (Figure 5).
Table I Analysis of D–JH coding joints
VprBPfl/+-Cre (n¼ 47) VprBPfl/+-Cre+ (n¼ 53) VprBPfl/fl-Cre+ (n¼ 47)
Number repeat 18/47 10/53 11/47
P/N addition
No P/N addition (%) 11/47 (23.4%) 9/53 (17.0%) 13/47 (27.7%)
Average P/N length 2.74±0.39 3.42±0.33 3.23±0.40
Range 0–12 0–9 0–9
D segment analysis
No deletion (%) 11/47 (23.4%) 19/53 (35.8%) 18/47 (38.3%)
Average deletion length 2.87±0.46 2.94±0.53 2.45±0.47
Range 0–15 0–20 0–18
JH4 segment analysis
No deletion (%) 9/47 (19.1%) 9/53 (17.0%) 10/47 (21.3%)
Average length deletion 4.13±0.44 5.75±0.60a (P¼ 0.044) 4.38±0.64
Range 0–13 0–16 0–21
Internal insertion/deletion/substitutionb 0/47 4/53 7/47a (P¼ 0.006)
Average length I/D/S 0 0.09±0.04 0.19±0.08a (P¼ 0.009)
Range 0 0–1 0–3
Microhomology 5/47 (10.6%) 6/53 (11.3%) 5/47 (10.6%)
Average length 2 2.33±0.67 2.6±0.4
Range 2 1–5 1–3
aSignificant in post hoc analysis by unpaired t-test versus VprBPfl/+-Cre.
bWithin the D or J gene segment. All base substitutions were transition mutations.
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DDB1 and VprBP form diverse E3 Ub ligase assemblies
involved in DNA replication, HIV replication, tumour
suppression and V(D)J recombination
VprBP was originally identified as a host interaction partner
to the HIV Vpr protein (Zhang et al, 2001), which plays a key
role in HIV infection by inducing G2 cell-cycle arrest to
promote HIV replication. The significance of this interaction
was revealed in later studies establishing that VprBP is a
member of a large family of WD40-repeat proteins that
generally serve as substrate receptors for the RING-type
Cul4/Roc1 E3 Ub ligase through association with the adaptor
protein DDB1 (Lee and Zhou, 2007). The endogenous sub-
strates that VprBP normally recruits to the DDB1/Cul4A/
Roc1 E3 Ub ligase complex for ubiquitylation may include a
tumour suppressor protein called NF2/Merlin (Huang and
Chen, 2008), but Merlin may alternatively act as an inhibitor
of this E3 Ub ligase complex (Li et al, 2010; Figure 8A).
DDB1/VprBP also services the HECT-type EDD E3 Ub ligase
through its association with the adaptor protein kinase
DYRK2 where it reportedly promotes ubiquitylation of kata-
nin (Maddika and Chen, 2009; Figure 8B). The finding here
that full-length RAG1 associates with the VDCR complex
extends the number and variety of E3 Ub ligase assemblies
that use DDB1/VprBP as adaptor and substrate recognition
subunits (Figure 8C). However, rather than recognizing
full-length RAG1 as a substrate, the evidence presented here
suggests full-length RAG1 alternatively recruits the VDCR
complex to direct its E3 Ub ligase activity. In the context of
the Cul4A/Roc1 and EDD E3 ligases, VprBP/DDB1 functions
to regulate DNA replication and cell-cycle progression. The
data presented here provide the first evidence that VprBP/
DDB1 also plays a role in regulating the processing and repair
of DNA breaks during V(D)J recombination. Identifying the
endogenous substrates of RAG1–VDCR complex-mediated
ubiquitylation will provide important mechanistic clues into




All animals were housed in individually ventilated micro-isolator
cages in an AALAC-accredited facility at Creighton University. All
procedures were conducted in accordance with federal and
institutional guidelines and approved by the University Institutional
Animal Care and Use Committee. VprBPfl/þ mice (provided by Y
Xiong) and mb1-Cre mice (provided by N Gupta with permission
from M Reth) have been previously described (Hobeika et al, 2006;
McCall et al, 2008). IgHEL-transgenic mice (Mason et al, 1992) were
purchased from Jackson Laboratory (Tg[IghelMD4]4Ccg).
Antibodies and immunoblotting
These reagents and procedures are described in the Supplementary
data.
VprBP identification
Purified FLMR1/cMR2 was subjected to SDS–PAGE, stained with
SYPRO Orange, and a gel slice containing p170 was excised from the
gel and analysed by mass spectrometry following a previously
published procedure (Ciborowski et al, 2007). VprBP was identified
from multiple peptides in two independent analyses (see
Figure 1B).
Protein expression and purification
Detailed procedures for the expression and purification of RAG,
VprBP/DDB1 and Roc1/Cul4A proteins can be found in Supple-
mentary data.
Electrophoretic mobility shift assay
Procedures for these assays have been described previously
(Bergeron et al, 2006). Briefly, a radiolabelled 12RSS or 23RSS
substrate was incubated with purified RAG and HMGB1 proteins (as
indicated), with or without VprBP/DDB1 and/or Cul4A/Roc1
(purified from insect cells), in binding buffer at 41C for 10 min.
For supershift assays, pre-immune or anti-VprBP anti-serum (1 ml),
or anti-VprBP antibody (1 mg) was added after the initial incubation
period and placed on ice for an additional 5 min. The complexes
were then separated on a 4% native polyacrylamide gel and
analysed as previously described (Bergeron et al, 2006).
Pull-down assays
Purified full-length or truncated VprBP protein (2.5mg; FL, D1, D5
and D8, respectively; see Figure 2A) and/or purified FLMR1/cMR2
(2.5mg) were incubated in IP buffer (1% IGEPAL, 300 mM NaCl,
20 mM Tris–HCl pH 7.5, 2 mM EDTA, 50 mM sodium fluoride,
0.4 mM sodium ortho-vanadate, 0.4 mM PMSF, 1 mM pepstatin A,
5mM leupeptin) in a final volume of (500ml) overnight at 41C under
gentle rotation. Anti-MBP antibody (2.5 mg) was added and
incubated an additional 2 h at 41C followed by addition of protein
A-agarose beads (50ml of 50% slurry; Pierce Thermo Scientific) pre-
washed three times in 1 IP buffer containing protease inhibitors
and 1mg/ml of BSA. The mixture was incubated for 2 h at 41C and
then the beads were washed three times with 1 IP buffer
containing protease inhibitors. The beads were resuspended in 50 ml
sample loading buffer and boiled, and then the supernatant was


































Figure 8 VprBP and DDB1 assemble diverse E3 Ub ligase com-
plexes. Models comparing different E3 Ub ligases containing the
adaptor and substrate receptor complex VprBP/DDB1. (A) In the
VDCR E3 ligase complex, Roc1 contains an RING (R) domain that
mediates ubiquitylation and associates with DDB1 and VprBP
through the scaffold protein Cul4A. (B) In the EDD–DYRK2–
DDB1–VprBP E3 ligase complex, EDD contains an HECT domain
that mediates ubiquitylation and associates with DDB1 and VprBP
through DRYK2 which functions both as an adaptor subunit and as
a protein kinase. (C) In the RAG1/2-Ku–VDCR complex, full-length
RAG1 associates with RAG2 and Ku, and interacts with the VDCR
complex through VprBP. The latter complex can function indepen-
dently of the RAG1 RING domain to mediate ubiquitylation.
Candidate substrates and inhibitors of each ligase complex are
indicated where known; some remain speculative.
VprBP binds RAG1 and guides B-cell development
MD Kassmeier et al
The EMBO Journal VOL 31 | NO 4 | 2012 &2012 European Molecular Biology Organization956
In-vitro ubiquitylation assays
Following previous reports (Simkus et al, 2009), in-vitro ubiquityla-
tion reactions (25ml final volume) were performed in reaction
buffer (40 mM Tris–HCl pH 7.5, 2 mM dithiothreitol, 5 mM MgCl2,
0.1 M NaCl, 2 mM ATP), and various components were added to the
reaction in different combinations as indicated: 400 mM myc–Ub,
50 nM rabbit E1 (UBE1) and 200 nM UbcH2, 3, 5a, 5b or 13 (all from
Boston Biochem, Cambridge, MA), and purified cMR1/cMR2,
FLMR1/cMR2, FLMR1 only or MR11–383 (300 ng). In some experi-
ments, reactions were further supplemented with full-length
VprBP/DDB1 (300 ng, purified from 293 cells), Cul4A/DDB1
(150 ng, purified from 293 cells), Ku70/Ku80 (350 ng, Trevigen,
Gaithersburg, MD), KPNA1 (178 ng, Origene Technologies, Rock-
ville, MD), or Histones H3.1, 3.2 or 3.3 (500 ng, New England
Biolabs, Ipswich, MA). Rabbit E1 was pre-incubated with myc–Ub
for 10 min at 371C in 1 reconjugation buffer (Boston Biochem);
the remaining components were incubated on ice for 30 min. The
two mixtures were then combined, and the reactions were
incubated for 2 h at 371C. The reaction mixture was then subjected
to SDS–PAGE and probed by immunoblotting.
Flow cytometry
Single cell suspensions prepared from bone marrow, spleen and
thymi of mice with the indicated genotypes were stained with
cocktails of fluorochrome-labelled antibodies or HEL as previously
described (Fusby et al, 2010). HEL (Sigma, St Louis, MO) was
conjugated to AlexaFluor 647 using a kit (Invitrogen, Carlsbad, CA).
All sample data collection and cell sorting were conducted using a
BD FACSAria flow cytometer. FACS purified bone marrow
B220þCD43þ and B220þCD43 populations cells were analysed
for apoptosis by staining with Annexin V and propidium iodide
using a commercially available kit according to the manufacturer’s
instructions (BD Biosciences), and evaluated for cell-cycle status by
with propidium iodide according to the method of Vindelov (1977).
All flow cytometric data were analysed using FloJo (TreeStar,
Ashland, OR) or ModFit LT (Verity Software, Topsham, ME).
V(D)J recombination assays
D–JH, VH–DJH and Vk–Jk rearrangements were amplified by PCR
from four-fold serially diluted genomic DNA prepared from bone
marrow (200, 50, 12.5 and 3 ng), and probed by Southern
hybridization using procedures described previously (Schlissel
and Baltimore, 1989; Schlissel et al, 1991). As a loading control, a
CD14 fragment was amplified by PCR in parallel (Schlissel et al,
1993). Gel-isolated D–JH4 amplicons were cloned using a TOPO-TA
Cloning Kit (Invitrogen). The cloned sequences were aligned to
known D and JH gene segments and the coding joints were analysed
to identify junctional insertions, deletions and microhomologies
(Gauss and Lieber, 1996).
Statistics
Data are presented as mean values±standard error of the means.
Collected data were subjected to analysis of variance and post hoc
testing using the PASW Statistics 19.0 software package (SPSS Inc.,
Chicago, IL). Differences with a P-value of o0.05 are considered
statistically significant.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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